Home Blog Page 10

SAMBÁZON Açaí Bowls Debut at Sobeys: A New Superfood Opportunity for Health Retailers

0

SAMBÁZON®, the leading Certified Organic and Fair Trade Açaí brand, has launched its popular frozen Açaí Bowls in Sobeys stores across Canada. Available in two flavours—Amazon Superberry and Berry Bliss—these ready-to-eat bowls feature sustainably harvested Açaí purée from the Brazilian Amazon and a crunchy, plant-based granola topping.

Designed for health-focused consumers seeking convenience without compromise, the bowls require no blending: simply thaw, add fresh fruit of choice and serve. Each bowl delivers a potent blend of antioxidants, fibre and healthy fats, making it an ideal breakfast option, post-workout snack or in-store sampler.

“For health retailers, SAMBÁZON’s entry into Sobeys represents a timely expansion of the superfood category,” says Vicki Isip, Chief Marketing Officer. “Our bowls combine premium nutrition with ethical sourcing, meeting consumer demand for both transparency and convenience.”

To support its Canadian growth, SAMBÁZON has partnered with iLevel Management for broker representation. Health food stores, pharmacies and natural product distributors interested in carrying the range can contact iLevel Management at 416-342-0213

Sobeys’ addition of SAMBÁZON Açaí Bowls underscores the rising consumer appetite for functional foods. Health retailers are encouraged to stock these Certified Organic and Fair Trade products to capitalize on the booming superfood segment and reinforce their commitment to sustainability and quality.

Canadian Food Inflation: Insights from Loblaw’s June 2025 Report

0

Loblaw Companies’ June 2025 Food Inflation Report shows that although monthly food-price increases slowed in May, the overall rate of food inflation remains notably above general inflation. As June ushers in Canada’s local growing season, grocers can anticipate some seasonal relief on produce prices. Still, commodity trends and currency movements will continue to exert significant influence on retail costs throughout 2025.

Summer Produce Boon: Local Growth Eases Prices

With the first heat of summer, many fresh fruits and vegetables transition from imported to Canadian fields. Local strawberries, asparagus, carrots, green onions and radishes—which once travelled three to four days from the United States or Mexico—are now harvested and ready for purchase within one to two days. This shift reduces transportation costs, eliminates foreign-exchange premiums and delivers superior freshness and shelf life. In practical terms, local field strawberries can be up to twenty percent cheaper than their imported counterparts at this time of year.

By July and August, Canadian growers supply the widest variety of local berries, stone fruits and garden vegetables. Price savings on these seasonal items often extend through to October, offering grocers and health-food stores an opportunity to promote “fresh-from-Canada” messaging and drive customer traffic. More broadly, Canada’s agricultural sector supports over two million jobs and funnels tens of billions of dollars of farm produce into grocery-store supply chains each year, underscoring the value of building strong partnerships with domestic growers.

Currency Fluctuations and Imported Goods

Global exchange rates play a leading role in the price of grocery commodities in Canada. Since the beginning of 2025, the United States dollar has weakened against the Canadian dollar amid ongoing investor uncertainty around U.S. fiscal health and trade policy. Because many staples—such as grains, oilseeds and coffee beans—are priced in U.S. dollars, a stronger Canadian dollar provides downward pressure on these import costs.

Conversely, the euro has grown more resilient relative to the Canadian dollar. This strength has offset some of the benefits from U.S.-dollar depreciation, particularly for euro-priced imports such as cheeses, deli meats, vinegars, olive oil and certain seafood. In the short term, grocers may notice only modest relief on European-sourced items despite favourable USD dynamics. For retailers, actively monitoring foreign-exchange trends and exploring fixed-price or hedged contracts can help stabilize costs. Where possible, pursuing Canadian alternatives to traditionally imported products will also mitigate currency risk.

Trends in Key Commodities

Beyond produce and exchange rates, several commodities are driving price movements in grocery and health-food categories this summer.

Rising beef prices, up more than sixteen percent year over year, reflect tighter supply in both fresh and frozen segments. These higher beef costs ripple through barbecue-season staples, prepared meals and deli offerings. Retailers can invite consumers to explore alternative proteins—such as chicken, pork or plant-based options—to ease budget pressures.

Sugar has fallen to a four-year low thanks to ample harvests in Brazil and India and a recent softening of global demand. Lower sugar prices present an opportunity to reduce input costs for bakeries, snack makers and beverage producers. Retail buyers should review supplier agreements now to lock in savings before a potential market rebound.

Olive oil and specialty vinegar prices have also eased somewhat due to the stronger Canadian dollar. Nonetheless, Mediterranean harvest variability means that these gourmet oils remain susceptible to weather-related swings and regional currency movements. Maintaining flexible supply arrangements and considering domestic canola- or sunflower-oil blends can help retailers manage that volatility.

Coffee, after months of volatility driven by weather and inventory uncertainty, has stabilized at levels roughly 150 percent above 2024 prices. With wholesale costs plateauing but inventories still elevated, grocers might differentiate their offering through private-label blends or premium Canadian roasts while justifying shelf prices with storytelling about origin and freshness.

Finally, cocoa bean prices continue to climb on the back of last year’s significant increases. Confectionery, baking chocolate and ready-to-drink hot-chocolate mixes will all feel the impact of these higher costs. Offering smaller pack sizes or value-bundled promotions—such as pairing chocolate with complementary items—can preserve perceived value even as input prices rise.

Strategic Takeaways for Retailers

To navigate these complex forces, Canadian grocery and health-food retailers can follow several strategic approaches:

Embracing local, seasonal sourcing helps reduce reliance on imports and strengthens customer trust. By building direct relationships with domestic growers and co-operatives, retailers ensure a steady supply of organic and specialty produce while bolstering “Canadian-fresh” marketing narratives.

Closely monitoring currency trends and diversifying supply chains will be critical. A hedging strategy or fixed-price contract for euro-denominated goods can protect margins, while expanding domestic procurement of staples such as dairy, meats and grains offers natural hedges against foreign-exchange fluctuations.

Adapting pricing and promotional tactics in real time empowers retailers to capitalise on short-term cost savings and maintain a transparent relationship with shoppers. Explaining why local berries can be offered at lower prices and why certain imports have become more expensive helps consumers feel informed and respected.

Strategic assortment and inventory planning are essential for maximizing profitability. Grocers should shift shelf space seasonally—expanding produce sections in summer and bulking up on stable, non-perishable items like sugar, flour and rice before anticipated price increases. Private-label or bulk sections also provide budget-conscious options for value-seeking customers.

Educating staff and customers about the drivers of food inflation builds goodwill. When team members understand why prices change, they can communicate confidently with shoppers. Highlighting the health benefits of seasonal, local foods—such as higher vitamin content in summer berries—reinforces both value and nutrition.

Maintaining agility in commodity buying and product offering will allow retailers to pivot when prices spike. Identifying and promoting suitable substitutes—like tea when coffee costs surge, or vegetarian proteins when beef prices climb—ensures continued customer engagement and consistent margins.

Finally, leveraging cross-selling and bundle promotions balances high- and low-cost items to protect profitability while delivering perceived value. For example, pairing in-season vegetables with alternative protein offerings as a “grill bundle” or combining pantry staples at a promotional price can drive basket size and share cost savings with customers.

Quebec Advances Safe Health Product Disposal, Yet Uptake Remains Slow

0

Quebec has made important strides in establishing take-back options for unused medications and used medical sharps, yet real-world participation remains lower than expected. The Health Products Stewardship Association (HPSA) released its 2025 consumer survey—conducted by Léger across six provinces, now including Quebec and New Brunswick for the first time—to gauge awareness, attitudes and disposal behaviours. More than 1,500 community pharmacies and several veterinary clinics serve as collection sites, underpinning a truly national stewardship programme.

Despite 59 per cent of Quebecers saying they know where to return unused medications and 67 per cent aware of sharps drop-off locations, nearly 40 per cent fail to adopt correct disposal behaviours. Although 85 per cent claim to understand what actions to take, just 74 per cent demonstrate true mastery of safe practices. Proper disposal entails sealing pills and powders in a clear plastic bag, leaving liquids and creams in their original containers, and placing sharps in a rigid, biohazard-marked box.

Some products continue to puzzle consumers—lotions, inhalers and natural health products often end up in household waste despite being present in nearly all Quebec homes. The survey found 97 per cent of households store prescription and over-the-counter medications, 84 per cent hold natural health products and 26 per cent possess medical sharps.

These disposal gaps carry environmental and public health risks. Improperly discarded pharmaceuticals can contaminate waterways (acknowledged by 67 per cent of respondents), soil (58 per cent) and even enter the food chain (49 per cent). The Canadian healthcare sector generates 5 per cent of national greenhouse-gas emissions, with pharmaceuticals accounting for 1 per cent. On the public health front, the Quebec Poison Control Centre logs over 50,000 potential poisoning cases annually—nearly half involving medications—and reports that accidental exposure ranks as the second leading cause of hospitalisation among children aged 0–4.

Addressing these challenges will require sustained public education, convenient collection points and collaboration across government, pharmacies and manufacturers to turn awareness into action.

Bridging the Nutritional Knowledge Gap for GLP-1 Agonist Users

0

Every so often, a leading brand reminds us that true innovation in health and wellness begins with asking the right questions rather than riding the latest trend. GNC has done just that by undertaking the first real-world nutritional analysis of GLP-1 agonist users, a pioneering effort that promises to reshape supplement formulation, clinical guidance and patient education for healthcare professionals.

 Bridging Clinical Trials and Daily Diet

GLP-1 receptor agonists such as semaglutide have transformed weight-management protocols, delivering remarkable results in controlled clinical trials. Yet those trials rarely reflect the complexities of everyday life – the hurried breakfast, the skipped snack, the reliance on convenience that comes with diminished appetite. Dr Brittany Johnson, PhD, RDN and Senior Manager of Scientific Affairs at GNC, recognized early on that formulating a support product without understanding real-world eating habits would risk missing the mark entirely. As she explains, “We set out last year to develop a product tailored to the unique needs of GLP-1 users. However, we quickly realized there simply wasn’t enough evidence to inform a formula based on our scientific standards.”

GNC researchers reviewing three-day food logs to capture authentic dietary patterns among GLP-1 agonist users.

By choosing to investigate true eating habits rather than rely on assumptions, GNC differentiates itself in a market awash with speculative claims. This commitment to data over conjecture sets a new benchmark for evidence-driven wellness retail.

Methodology

GNC’s study, Investigating Nutrient Intake During Use of Glucagon-like Peptide-1 Receptor Agonist: A Cross-Sectional Study, enrolled sixty-nine adults who had been on stable GLP-1 therapy for at least eight weeks. Participants logged every morsel and sip over a representative three-day period, noting portion sizes, preparation methods and mealtime contexts. This rigorous dietary survey was paired with validated nutritional analysis software to calculate macronutrient and micronutrient intakes. To assess protein adequacy, intake was expressed not only as a percentage of total calories but also in grams per kilogram of body weight, offering a body-weight-adjusted perspective that is vital for maintaining lean mass. Data accuracy was assured through double-entry coding and independent review by registered dietitians, eliminating common pitfalls of under- or over-reporting.

Such granularity – capturing everything from the fibre in a handful of berries to the calcium in a side of steamed broccoli – reveals a far more nuanced picture of how appetite suppression influences nutrient intake beyond simple calorie counts.

 Shortfalls Among GLP-1 Users

The results were both illuminating and concerning. Participants consistently failed to meet recommended servings for fruits, vegetables, whole grains and dairy, falling well below UK Public Health England and USDA MyPlate guidelines. Though total fat and saturated fat provided an excessive proportion of daily energy, this likely reflects a tendency to opt for higher-fat convenience foods when appetite re-emerges sporadically.

Most striking was the finding that mean protein intake, while accounting for 15–20 per cent of total calories, translated to only 0.6 grams per kilogram of body weight, significantly under the 0.8 g/kg threshold recommended for preserving muscle mass and metabolic health. Without sufficient protein, patients risk losing lean tissue, which can undermine both functional capacity and long-term metabolic control.

Micronutrient analysis revealed substantial deficits in fibre, calcium, iron, magnesium, potassium, choline and the antioxidant vitamins A, C, D and E. Such deficiencies have far-reaching implications, from compromised bone density and immune resilience to impaired recovery from exercise and reduced antioxidant defence. In short, the very therapy that delivers critical metabolic benefits could inadvertently create new nutritional vulnerabilities if left unaddressed.

Bar chart comparing average nutrient intake against Dietary Reference Intakes, highlighting critical gaps in fibre, protein and micronutrients.

Translating Findings into  Strategies

Rachel Jones, MS, RDN and GNC’s Chief Merchandising & Science Officer, emphasizes that “science is the foundation for everything we do at GNC.” Armed with concrete evidence of nutrient shortfalls, practitioners can now recommend tailored interventions rather than generic advice. Clinicians and dietitians will be able to integrate body-weight-adjusted protein targets and specific micronutrient monitoring into routine therapy reviews, ensuring that patients receive personalized nutrition plans alongside their prescriptions.

On the product side, GNC is already leveraging these insights to refine its GLP-1 support programme. Future supplement formulations will be designed to plug the precise gaps identified – for example, a protein-fortified shake enriched with calcium, magnesium and vitamin D to support bone health and immune function. Educational materials, from meal-planning guides to digital recipe libraries, will spotlight nutrient-dense foods that help patients meet targets without overwhelming their reduced appetites. Rather than treating side effects like nausea or fatigue in isolation, GNC’s approach will address the root cause: suboptimal nutrient intake.

Charting the Path

For health industry professionals – whether in practice, research or product development – GNC’s real-world analysis signals a clear imperative: supplement innovation must be as evidence-based as the therapies it seeks to support. Pharmaceutical companies and wellness retailers alike should forge partnerships to conduct post-marketing surveillance on nutrient status among GLP-1 cohorts, creating a continuous feedback loop that refines clinical guidelines and product portfolios in real time. Regulatory bodies may also look to these findings when considering labelling requirements and health claims for support supplements, emphasizing the need for transparency and substantiation.

Looking ahead, GNC plans to expand its research to larger, more diverse populations and to explore intervention trials that assess the impact of targeted supplementation on clinical endpoints such as bone density, metabolic biomarkers and patient-reported quality of life. By demonstrating that robust science can underpin credible, consumer-centric solutions, GNC is not only raising the bar for supplement retailers but also equipping healthcare professionals with the tools they need to safeguard patient health in the era of GLP-1 agonist therapy.

Diversification and Domestic Production

0

Health-food manufacturers and suppliers are likewise scrambling. CHFA and the Canadian Organic Trade Association (COTA) are advising members to diversify markets and supply chains. COTA emphasizes that many organic inputs have alternative sources: new 8-digit HS codes for organics mean many U.S.-origin organic products may be exempt from retaliatory tariffs, canada-organic.ca. Both associations urge businesses to leverage Canada’s nine organic equivalency arrangements (with the EU, UK, Japan, Mexico, etc.),  to offset any U.S. bottleneck. On the supply side, manufacturers are reviewing contracts, invoking “force majeure,” or renegotiating terms, and exploring new raw material sources. For example, the supplement industry’s U.S. peers have publicly suggested seeking vitamin and mineral ingredients from South Korea or India instead of the typical Chinese suppliers. In Canada, ingredient brokers report already diversifying – one Ontario retailer cited in Canadian Grocer said domestic greenhouse farms and alternate producers are being lined up to replace potential U.S. fruit and vegetable shortfalls.

In some cases, the trade war has even sparked talk of reshoring. CHFA president Aaron Skelton notes that before tariffs, some Canadian supplement companies had moved manufacturing to the U.S. to cut costs. With the prospect of a 25% duty on U.S.-made products, these firms are reevaluating their strategies. “If there’s a silver lining, it’s that this could ultimately put the sector on a stronger footing,” Skelton told the media, referring to a renewed push for homegrown production. Industry leaders are lobbying for federal support to build domestic capacity – from easing interprovincial trade barriers to regulatory relief – so Canada can better supply its market in future. For now, companies are stockpiling inputs and highlighting “Made in Canada” on labels as part of a nationalistic wave.

Government Relief and Support Programs

Ottawa and the provinces are rolling out aid to offset higher costs. In April, the federal budget unveiled a Trade Impact Program – $5 billion over two years – to help exporters find new markets and navigate losses from tariffs (covering cash-flow gaps, currency swings, etc.). Additional funding includes up to $500 million in low-interest loans via the Business Development Bank of Canada (BDC) for tariff-affected sectors (plus advisory support on finance and market diversification), and $1 billion from Farm Credit Canada to assist agriculture and food businesses with cash flow.  The Canada-U.S. transition also qualified small businesses for deferred tax relief: corporate income tax and GST/HST remittances can be postponed from April 2 to June 30, 2025 (freeing roughly $40 billion in liquidity) cfib-fcei.ca. Other measures include an enhanced AgriStability program, expanded Work-Sharing benefits (to avoid layoffs during downturns), and a government tariff “remission” process to grant exceptional relief in dire cases. Provincial agencies like Invest Ontario and provincial development banks are also offering targeted support for food and NHP firms. Industry associations lobby constantly to ensure health-food businesses access these programs, while educating members on export grants (CanExport SMEs), buying embassies’ procurement portals, and risk-management tools.

Short-Term Outlook

In the near term, the Canadian health-food sector faces a bumpy road. U.S. tariffs could add 10–25% to the cost of American-origin ingredients and finished goods, and Canadian levies likewise hit U.S.-sourced inputs. However, key exemptions and relief will soften the blow. Small direct imports remain duty-free for now, and businesses can apply for remission if they show hardship. Retailers are already compensating with higher margins on foreign goods and shifting inventory, and eager domestic consumers should help sustain demand for Canadian-made NHPs and organics. According to industry research, over 80% of Canadians use supplements, and 70% say they actively look for local foods – a sentiment only strengthened by the trade fight.

Longer run, some uncertainty remains. A USMCA (CUSMA) review is slated for 2026 chfa.ca, and future Canadian elections could change federal priorities. Ongoing regulatory challenges – such as Canada’s pending plain-language labelling rules and cost-recovery fees for NHPs – add complexity. Still, trade experts stress that preparation is key. Companies are advised to inventory inventories, renegotiate suppliers, and even diversify into new segments (e.g. hemp/CBD, botanical extracts or functional foods) to broaden resiliency. If the tariff skirmish turns into a prolonged economic Cold War, one silver lining may be a stronger local supply chain: building Canadian capacity and export markets is now “long overdue,” in the words of CHFA’s CEO.

Government contacts and industry resources (timeline of tariff announcements, export funds, etc.) are being updated constantly – businesses should monitor Finance Canada and CHFA/COTA bulletins for the latest changes. In the meantime, the coming months will test the sector’s agility. With consumers and retailers championing Canadian goods, and millions in relief at hand, the health-food industry’s focus is on staying the course: diversify supply, optimize costs, and make “Made in Canada” the new symbol of quality in a tense trade climate.

French Maritime Pine Bark Extract (Pycnogenol®) Rises as a Clinically Proven “Beauty-From-Within” Solution for Cellulite

0

An IHR Magazine Editorial for Health Retailers and Brand Managers

The original French maritime pine bark extract, Pycnogenol® has over four decades of peer-reviewed research and clinical validation in vascular health, chronic venous insufficiency and now, cellulite reduction.

Cellulite remains one of the most persistent cosmetic concerns for women, affecting up to 98 percent of the female population. Traditional approaches—from topical creams to radiofrequency and laser devices—often require multiple sessions, deliver only modest improvements and carry significant time and financial costs. Today’s wellness consumer demands convenience, transparency and proven results. A landmark clinical trial now positions Pycnogenol® as a differentiated, oral “beauty-from-within” solution that delivers on those expectations.

Clinical Study Overview

Between November 2021 and February 2022, a single-centre, randomized, double-blind, placebo-controlled trial in Beijing enrolled 66 women aged 25 to 45 with clinically assessed moderate cellulite. Participants received a daily 150 mg dose of Pycnogenol®, standardized to 70 ± 5 percent procyanidins, or a visually identical placebo. Over the 12-week period, sixty participants completed the protocol, and no adverse events were reported, underscoring the extract’s excellent safety profile.

By week 12, those supplementing with Pycnogenol® experienced a 13.6 percent reduction in the Hexsel Cellulite Severity Score, compared with no significant improvement in the placebo group. Objective measurements revealed an average decrease of 2.07 cm in upper-thigh circumference, more than double the reduction seen with many energy-based treatments. Skin-surface analysis demonstrated a 32 percent decrease in roughness and a 10 percent improvement in smoothness, confirming that benefits extend beyond clinical scores to visibly smoother, firmer skin.

Why This Matters for Retailers

These results arrive at a pivotal moment. Consumers no longer settle for unsubstantiated claims. They seek science-backed solutions that fit easily into busy lives. Pycnogenol® fulfils this demand by offering a once-daily supplement whose efficacy is proven in a gold-standard clinical trial. Its forty-year heritage of research—from microcirculation improvements in cardiovascular health to its latest application in dermatology—lends credibility that resonates with informed shoppers. By incorporating Pycnogenol® into your portfolio, you can address a widespread consumer need for effective cellulite management while differentiating your store in a competitive wellness market.

Merchandising and Marketing Strategies

Effective presentation of Pycnogenol® begins with clear storytelling. Packaging and in-store signage should highlight the headline outcome—over 2 cm of thigh reduction in 12 weeks—and reference the full study DOI for authenticity. Rather than relegating the product to a generic supplement aisle, position it within a dedicated “Skin Renewal” or “Beauty Boost” fixture alongside complementary offerings such as collagen peptides and vitamin C. Trial-size sachets or 30-day starter kits lower the barrier to first purchase, while carefully crafted gift-with-purchase promotions encourage repeat business.

Frontline staff empowerment is equally essential. Concise training on Pycnogenol®’s patented procyanidin profile and its mechanism—enhancing microcirculation, reducing oxidative stress and supporting vascular endothelium—equips team members to engage confidently with customers and answer questions with authority. Digital channels further amplify your message: before-and-after images shared (with consumer consent) on social media bring clinical data to life, while expert webinars or retailer-hosted panels position your brand as a thought leader in evidence-based beauty. Strategic email campaigns that trace Pycnogenol®’s research pedigree from its origins in southern France to the latest cellulite trial create a compelling narrative that guides consumers from awareness to purchase.

Conclusion

In an industry crowded with fleeting trends and unsupported assertions, Pycnogenol® stands apart as the original French maritime pine bark extract underpinned by rigorous human studies. By championing this clinically validated ingredient, health retailers and brand managers can offer a truly differentiated, effective and research-backed solution to cellulite. Embracing Pycnogenol® not only meets consumer demand for convenient, non-invasive options but also elevates your store’s reputation as a destination for premium, science-led wellness.

Five Emerging Health & Wellness Trends Shaping 2025 Natural Health Retail

0

Actionable insights for natural health retailers to capitalize on functional nutrition, innovative delivery formats and cutting-edge longevity ingredients.

The Vitamin Shoppe’s 2025 Health & Wellness Trend Report reveals five pivotal movements that are reshaping Canadian supplement and functional food retail. By understanding these developments and weaving them into merchandising, marketing and educational strategies, independent retailers can deepen customer trust and unlock new avenues of growth.

Functional Protein Foods and Ready-to-Drink Beverages
The days of relying solely on powder tubs are giving way to on-the-go nutrition formats. Year-to-date sales at The Vitamin Shoppe indicate that ready-to-drink protein beverages have surged by 20 per cent, while protein bars and snacks have climbed by 28 per cent, even as powders declined by 12 per cent. For retailers, this trend presents an opportunity to spotlight grab-and-go options at point of sale, arrange tasting events that encourage trial, and pair complementary items, such as adaptogen shots alongside energy bars, to boost basket size and impulse purchases.

The NAD⁺ Longevity Revolution
Consumer interest in cellular-health supplements has exploded. Searches for NAD⁺ precursors—nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—spiked nearly 500 per cent this year, driving a 91 per cent growth in the healthy-aging category in Q1. To capitalize on this wave, retailers should equip staff with a deep understanding of how precursors differ from direct NAD⁺ supplementation and develop dedicated longevity sections both in-store and online. Digital newsletters featuring clinical data and founder-origin stories can reinforce credibility and foster loyal followings among customers seeking age-management solutions.

Peptides as Performance Enhancers
Once confined to the beauty cabinet, peptides are now racing into sports nutrition aisles. Searches for peptide-enhanced products climbed over 550 per cent in 2025, with formulations like “AN Performance Creatine + Peptide” leading the charge. Retailers can harness this momentum by hosting athlete meet-and-greets in flagship locations, distributing mini-reports via QR codes that explain peptide mechanisms and benefits, and running targeted promotions that frame peptides as essential tools for recovery, strength and overall athletic performance.

Beyond Pills: Alternative Delivery Formats
Convenience remains king as consumers seek simpler ways to integrate supplements into busy lives. Liquid vitamins have posted a 50 per cent jump in sales, and creatine gummies have seen a staggering 1,300 per cent surge in online searches. Gummies, beadlets and topical sprays not only differentiate retail assortments but also enhance compliance. Retailers can maintain customer engagement by rotating format spotlights, such as featuring a “Liquid of the Week” display, and offering sampling stations that encourage shoppers to experiment with novel delivery systems.

Shilajit’s Modern Resurgence
This ancient Ayurvedic resin is experiencing a revival, climbing over 40 per cent in sales during the first quarter. Valued for its rich fulvic-acid and mineral profile, shilajit resonates with consumers seeking natural energy, immune support and cognitive clarity. Retailers are encouraged to host educational workshops on adaptogens, curate bundle promotions pairing shilajit with complementary botanicals like ashwagandha and sea moss, and tell compelling sourcing stories that highlight heritage and sustainability, thus forging emotional connections with customers.

Integrating Trends into Retail Strategy
To transform these insights into sales momentum, Canadian health retailers should reimagine store layouts by lifestyle theme, creating zones such as “Longevity Lab” or “Functional Fuel” to facilitate discovery. Investing in regular staff training and vendor-led demonstrations will ensure teams speak confidently about emerging ingredients. Digital channels can preview in-store launches and sample events, driving foot traffic and blending physical with online experiences. Cross-merchandise trending ingredients to foster trial and increase transaction values, while aligning promotions with local search behaviour and inventory data to optimize stock levels and marketing spend.

By embracing functional protein formats, the NAD⁺ longevity movement, peptide-driven performance, alternative delivery systems, and the resurgence of shilajit, natural health retailers can position themselves as trusted wellness destinations in 2025. Strategic merchandising, education and omnichannel storytelling will not only meet consumer expectations but also build loyalty and sustainable growth well into the future.

Brightseed Launches Bio Gut Core™: Clinically Proven AI-Discovered Ingredient for Gut Health

0

Brightseed, a San Francisco-based bioactives company, has launched Bio Gut Core™, a new nutraceutical ingredient clinically proven to strengthen the gut barrier and improve digestive wellness within weeks. Developed using Brightseed’s proprietary Forager® artificial intelligence platform, Bio Gut Core is a low-dose, ready-to-use ingredient designed for supplements and functional foods. Its debut comes alongside fresh human trial data demonstrating significant benefits for gut health, including enhanced gut barrier function and reduced bloating and abdominal discomfort, in as little as three weeks of use.

Digestive health is a major consumer priority and economic opportunity, with the global digestive health products market valued at over $51 billion. In the United States alone, an estimated 60–70 million people suffer from digestive diseases. Consumers are actively seeking solutions that target the gut barrier, an often-overlooked aspect of gastrointestinal health: according to Brightseed, 88% of surveyed consumers want products to help restore gut barrier function. The gut barrier serves as a critical “shield” in the digestive tract – it fosters a balanced microbiome, enables nutrient absorption, and blocks toxins from entering the bloodstream. A weakened barrier (sometimes called “leaky gut”) can lead to dysbiosis, inflammation, and symptoms like bloating and digestive pain. Until now, formulating supplements to support gut barrier integrity has been challenging, often requiring impractically large doses with limited efficacy. Brightseed’s Bio Gut Core aims to change that with a science-backed, concentrated solution.

AI-Powered Discovery of Key Gut Health Bioactives

https://www.businesswire.com/news/home/20250521978816/en/Brightseed-Debuts-Bio-Gut-Core-a-Low-Dose-Digestive-Health-Ingredient-Clinically-Proven-to-Strengthen-Gut-Barrier-and-Reduce-Bloating-and-Abdominal-Pain-in-Just-Three-Weeks

 Brightseed’s proprietary Forager AI platform identified two bioactive compounds (NCT and NFT) from common plant sources to power the new Bio Gut Core™ ingredient. These natural compounds were discovered in dozens of ubiquitous plants, such as garlic and black pepper, using AI-driven analysis. The discovery exemplifies how advanced technology is uncovering nature’s solutions for human health.

Bio Gut Core’s effectiveness stems from a proprietary blend of two phytonutrients that Brightseed’s Forager® AI discovered in nature: N-trans-caffeoyltyramine (NCT) and N-trans-feruloyltyramine (NFT). These bioactive compounds were identified across many common plants (including garlic and black pepper) as having a unique impact on gut health. Research by Brightseed found that NCT and NFT act as agonists for HNF4α, a transcription factor known to play a key role in maintaining gut barrier integrity. In other words, the compounds activate a biological pathway that fortifies the gut lining. This mechanistic insight helps explain the observed benefits: by targeting HNF4α, NCT and NFT help support a stronger, less permeable intestinal barrier, which is crucial for overall digestive health.

Notably, Bio Gut Core delivers these benefits in a low-dose format, making it easy to incorporate into supplements and functional foods. “Bio Gut Core brings together two clinically-proven bioactives in one product to enable a more complete digestive health solution and effectively target the gut barrier,” Brightseed explained. This marks a breakthrough given that previous approaches to gut barrier support often required high doses or large volumes of fibre. By leveraging AI to pinpoint high-potency natural compounds, Brightseed has created an ingredient that achieves meaningful results with a small, convenient dose.

Clinically Validated Benefits in Just Three Weeks

The launch of Bio Gut Core is backed by results from a new double-blind, randomized, placebo-controlled trial on its bioactive components. In the study, participants who took the NCT+NFT blend experienced a significant improvement in gut barrier function after only three weeks, compared to placebo. They also reported notably less abdominal distension (bloating) and reduced digestive discomfort within the same period. Impressively, some individuals began noticing relief after just one week of supplementation, highlighting the ingredient’s rapid onset of action.

Beyond the quantitative clinical outcomes, Brightseed has highlighted the real-world impact on participants’ quality of life. Study participants provided glowing testimonials about their digestive improvements. One individual described the difference after a week of taking Bio Gut Core as “night and day,” noting they had “the best two weeks in a long time” once the supplement kicked in. Another participant called the experience “absolutely life changing” and said it “has given me some quality of life back”. These firsthand accounts reinforce the clinical data and put a human face on the results, suggesting that Bio Gut Core could offer tangible relief for people suffering from chronic gut issues.

Brightseed’s scientific team underscores that the trial results represent an important validation of their AI-guided discovery approach. “This study provides clinical proof that bioactives NCT and NFT significantly improve gut barrier function, delivering a much-needed solution to health companies and consumers alike,” said Swati Kalgaonkar, Brightseed’s Head of Medical & Scientific Affairs and Clinical Research. Equally noteworthy, Kalgaonkar added, are the dramatic improvements reported by participants – outcomes she said are “even more exciting than the clinical data” and “the reason Brightseed exists”.

The human study was commissioned by Brightseed and is currently under peer review, with anticipated publication in a scientific journal later this summer. The company is also sharing the findings with the scientific community: Brightseed is scheduled to present results from the trial at the upcoming American Society for Nutrition (ASN) NUTRITION 2025 conference on May 31, 2025. The conference session, entitled “From Side Stream to Mainstream: How AI-Discovered Bioactives Are Revolutionizing Gut & Metabolic Health Benefits in Consumer Goods,” will spotlight Bio Gut Core’s development as an example of AI-driven innovation in nutrition.

Addressing the $51 Billion Digestive Health Market

With gut health continuing to dominate wellness trends, Brightseed’s new ingredient comes at an opportune time for the industry. The digestive health products sector – from supplements to functional foods – is enormous and growing, estimated at over $50 billion globally.  A large segment of consumers struggles with persistent digestive issues like IBS, “leaky gut,” and related metabolic conditions, driving demand for more effective solutions. Lee Chae, PhD, Brightseed’s co-founder and CEO, noted that Bio Gut Core represents a “novel, nature-derived ingredient” entering the $51 billion digestive market, and described it as a “next-level solution” to provide relief for the “tens of millions of Americans” affected by debilitating digestive conditions.  By delivering clinically validated efficacy in a convenient form, Bio Gut Core gives supplement manufacturers and wellness brands a new tool to address these widespread consumer needs.

Chae also emphasized that the successful development of Bio Gut Core validates Brightseed’s broader platform and mission. The positive clinical results “further validate the ability of Brightseed’s AI-driven discovery to meaningfully improve human health and quality of life,” he said. Bioactives identified by artificial intelligence and backed by rigorous trials can rapidly translate into market-ready health products – a paradigm that could accelerate innovation across the nutraceutical industry. Brightseed has signalled that Bio Gut Core is just the beginning, with “big plans from here” as it expands its pipeline of AI-discovered, science-backed ingredients. The company’s portfolio already includes offerings like Bio Gut Fibre (an upcycled hemp fibre ingredient rich in the same bioactives NCT and NFT), and it plans to unveil additional bioactive-based solutions targeting other areas of health.

Innovating Nutraceuticals for Digestive Wellness

Brightseed’s launch of Bio Gut Core™ illustrates a growing trend at the intersection of technology and natural products in the nutraceutical sector. By harnessing AI to uncover efficacious plant compounds and validating them through clinical research, companies like Brightseed are pioneering a new model of evidence-based innovation in digestive wellness. For healthcare practitioners and product formulators, this AI-discovered ingredient offers a novel approach to strengthening gut health, one that is rooted in nature yet demonstrated with scientific rigour. As digestive wellness remains a top priority for consumers, Bio Gut Core signals how cutting-edge discovery methods can unlock next-generation nutraceuticals. This convergence of AI technology, clinically proven efficacy, and unmet market needs sets a promising precedent for the future of gut health solutions and functional ingredients in the wellness industry.

SFI Health EMEA Localises Key Brand Packaging in South Africa

0

SFI Health™ EMEA, the regional division of global natural healthcare leader SFI Health™, has announced a strategic shift to localize the packing of its key product brands in South Africa. This move leverages domestic manufacturing capabilities and talent, reinforcing the company’s commitment to the South African market and economy.

Operating through its South African subsidiary since 2004, SFI Health™ offers a portfolio of clinically researched natural health supplements focused on microbiome, cognition, and overall well-being. The transition to local packing will enhance operational flexibility, enabling the company to tailor pack sizes more precisely to consumer demands while maintaining its high standards for product quality and efficacy.

Susan Lewis, Head of Sales Direct Markets EMEA and co-leader of the initiative, highlighted the broader significance of the project:
“This initiative goes beyond business optimization; it is a deliberate investment in our local communities. By sourcing packaging materials and labour domestically, we strengthen the regional supply chain, support local jobs, and contribute to South Africa’s economic resilience.”

This localization strategy aligns with SFI Health™’s sustainability objectives, reducing environmental impact by minimizing transportation needs and promoting a circular, locally anchored supply chain.

South Africa’s growing consumer market will benefit from improved availability and accessibility of SFI Health™’s key brands, which include:

  • Equazen® – A globally respected product formulated with essential fatty acids to support cognitive health.
  • KeenMind® – Clinically studied to enhance memory, concentration, and learning retention.
  • Gincosan® – Combines standardized Ginkgo biloba and Panax ginseng extracts to combat mental fatigue and improve cognitive function.
  • Ginsana® – Utilizes a proprietary natural ingredient to support immune function and physical endurance.

Headquartered in Australia, SFI Health™ operates across more than 50 countries, with its EMEA regional office in Lugano, Switzerland, overseeing commercial activities across Europe, the Middle East, and Africa. The company combines a pharmaceutical rigour with natural health solutions, advancing confidence in natural healthcare through evidence-based products and collaborative partnerships with healthcare professionals worldwide.SFI Health EMEA Localizes Key Brand Packaging in South Africa

Scarborough Health Network Receives $1 Million Gift from Sue Nathan and Roy Ratnavel to Support Mental Health Care

0

Scarborough Health Network Receives $1 Million Gift from Sue Nathan and Roy Ratnavel to Support Mental Health Care

In a powerful testament to the strength of community and the transformative power of giving, Sue Nathan and Roy Ratnavel have donated $1 million to the Scarborough Health Network (SHN) Foundation, earmarked for expanding inpatient mental health services at Birchmount Hospital.

The significance of this gift runs deeper than dollars and cents. For Roy Ratnavel—a former political prisoner in Sri Lanka, survivor of civil war, and acclaimed author of Prisoner #1056—the cause is profoundly personal. After immigrating to Canada at 18 and building a distinguished career in finance, Ratnavel has remained deeply connected to Scarborough, the community that first welcomed him and his family.

“It’s crucial that we address the mental health needs of our community with compassion and understanding,” Ratnavel shared. “Sue and I are proud to support Scarborough Health Network in their vital work. My own experiences have shown me the importance of accessible and culturally sensitive mental health support, and we hope this gift will help to break down barriers and reduce stigma.”

Expanding Access to Mental Health Services

Scarborough Health Network is home to Ontario’s second-largest community-based mental health program, serving over 65,000 outpatients, 7,500 inpatients, and handling more than 10,000 referrals every year. These figures highlight the pressing need for expanded, equitable, and stigma-free mental health services in one of Canada’s most diverse regions.

The $1 million donation from Sue Nathan and Roy Ratnavel will directly support the expansion of inpatient mental health facilities at Birchmount Hospital, enabling SHN to reach more vulnerable individuals facing persistent mental health challenges and complex care needs. The gift also advances SHN’s ongoing efforts to provide culturally responsive care, an issue close to Ratnavel’s heart, particularly within the Tamil community and other newcomer populations.

“We are inspired by Roy’s story and incredible resilience, and grateful to Roy and Sue for their commitment to improving mental health care in Scarborough,” said Alicia Vandermeer, President & CEO of SHN Foundation. “This donation will make a substantial difference in the lives of individuals and families facing mental health challenges.”

Supporting the “Love, Scarborough” Campaign

This historic gift also supports the Love, Scarborough campaign, a bold fundraising initiative launched in 2022 by the SHN Foundation. The campaign aims to raise awareness and critical funds for Scarborough’s three hospitals, supporting emergency care, pioneering new healthcare models, and advancing research and education across the network.

With the slogan “SHN does more than anyone thought possible with less than anyone could imagine. Imagine what they could do with more,” the campaign calls attention to both the needs and the immense potential of Scarborough’s health system. Learn more at lovescarborough.ca.

About Scarborough Health Network

SHN is shaping the future of care for one of Canada’s most dynamic and multicultural communities. With three hospitals and several community-based sites, SHN provides essential and specialized health services and is an academic leader through partnerships with the University of Toronto and the Scarborough Academy of Medicine and Integrated Health.

Supported by visionary donors like Nathan and Ratnavel, SHN is building forward with innovation, inclusivity, and a relentless commitment to health equity.